KalVista Pharmaceuticals
KalVista Pharmaceuticals Logo
About KalVista Pharmaceuticals
KalVista Pharmaceuticals Inc is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral protease inhibitor drugs for the treatment of hereditary angioedema (HAE), a rare genetic disease characterized by unpredictable and potentially life-threatening swelling attacks. Its lead product candidate, Sebetralstat, is a small molecule plasma kallikrein inhibitor targeting HAE. The company is also developing Factor XIIa oral inhibitors and various formulations for pediatric and adult HAE patients. KalVista Pharmaceuticals serves customers worldwide and is headquartered in Cambridge, Massachusetts.
Address
55 Cambridge Parkway, Suite 901 East
Cambridge, 02142
United States
Year founded
2004
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
